Peak Bio, Inc.Peak Bio, Inc.Peak Bio, Inc.

Peak Bio, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪194.64 K‬USD
‪−13.09 M‬USD
‪607.68 K‬USD
‪7.91 M‬
Beta (1Y)
4.92

About Peak Bio, Inc.

CEO
Stephen J. LaMond
Headquarters
Pleasanton
Founded
2016
FIGI
BBG00YVT97J2
Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease. The company is headquartered in Pleasanton, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PKBO is 0.0086 USD — it hasn't changed in the past 24 hours. Watch Peak Bio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Peak Bio, Inc. stocks are traded under the ticker PKBO.
Peak Bio, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
PKBO stock is 0% volatile and has beta coefficient of 4.92. Track Peak Bio, Inc. stock price on the chart and check out the list of the most volatile stocks — is Peak Bio, Inc. there?
Yes, you can track Peak Bio, Inc. financials in yearly and quarterly reports right on TradingView.
PKBO stock has risen by 1.18% compared to the previous week, the month change is a 65.38% rise, over the last year Peak Bio, Inc. has showed a 98.92% decrease.
No, PKBO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PKBO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Peak Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
PKBO reached its all-time high on Oct 27, 2022 with the price of 14.9997 USD, and its all-time low was 0.0020 USD and was reached on Feb 22, 2024. View more price dynamics on PKBO chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Peak Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Peak Bio, Inc. stock shows the sell signal. See more of Peak Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.